In addition to the insulin replacement therapy, the recent advancement in the therapeutic targets also includes a multicentre randomized clinical trial to examine the effect of IL-1 antagonism on beta cells in T1D, since IL-1β was found to induce apoptosis of pancreatic beta cells [91, 92]. Here, INS is linked to type 1 diabetes mellitus.